O002/#43 Randomized Phase 3 Study of Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer (Aec): Subgroup Analysis of Patients with Dna Mismatch Repair Deficient (Dmmr) Tumors

AuthID
P-00V-TAV
20
Author(s)
Makker, V
·
Colombo, N
·
Casado Herráez, A
·
Santin, A
·
Colomba, E
·
Fujiwara, K
·
Pignata, S
·
Banerjee, S
·
Monk, B
·
Ushijima, K
·
Penson, R
·
Kristeleit, R
·
Fabbro, M
·
Orlando, M
·
Mackay, H
·
Ren, M
·
Orlowski, R
·
Dutta, L
·
Lorusso, D
Document Type
Proceedings Paper
Year published
2021
Published
in Oral Abstracts
Indexing
Publication Identifiers
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.